Direkt zum Inhalt
Merck

Fortfahren mit

C3660

Complement C9 from human serum

≥150,000 C9H50 units/mg (using C9 deficient serum)

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
Größe/SKUVerfügbarkeitPreis
0.1 mg
Warenkorb auf Verfügbarkeit prüfen
€ 329,00

Über diesen Artikel

CAS-Nummer:
UNSPSC Code:
12352202
NACRES:
NA.61
MDL number:
eCl@ss:
32040503
Form:
solution
Assay:
≥85% (SDS-GE)
Biological source:
human

€ 329,00


Warenkorb auf Verfügbarkeit prüfen

​
Sonderanfertigung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


biological source

human

Quality Segment

assay

≥85% (SDS-GE)

form

solution

specific activity

≥150,000 C9H50 units/mg (using C9 deficient serum)

UniProt accession no.

application(s)

cell analysis

shipped in

dry ice

storage temp.

−70°C

Gene Information

human ... C9(735)

Application

Complement C9 from human serum is an essential part of the terminal complement system. It has been a topic in cancer research, where extracellular phosphorylation by ecto-PK of K562 cells on serine residues may serve as a protective mechanism against complement in tumor cells. Additionally, it can be used as a biomarker (in fucosylated form) for squamous cell lung cancer, as patients tend to show elevated levels of C9 protein.

Biochem/physiol Actions

Complement component C9 is the final component of the membrane attack complex (MAC) responsible for cell lysis by complement. CD59 binds to both C8 and C9 and prevents assembly of an active MAC, protecting cells against lytic activity.

Physical form

Supplied as a solution in phosphate buffered saline, pH 7.2.

Analysis Note

Functionally pure by a sensitive hemolytic assay using deficient sera.

Other Notes

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
204910C3535C1163
description

≥150,000 C9H50 units/mg (using C9 deficient serum)

description

Complement C9, Human, CAS 80295-59-6, is a native, single-chain glycoprotein present in normal human serum at 60 µg/ml.

description

suitable for radioiodination, RIA, ≥85% (SDS-PAGE), ≥125,000 C8H50 units/mg protein (using C8 deficient serum)

description

for complement assays

biological source

human

biological source

-

biological source

human

biological source

human

assay

≥85% (SDS-GE)

assay

≥95% (SDS-PAGE)

assay

≥85% (SDS-PAGE)

assay

-

form

solution

form

liquid

form

solution

form

solution

storage temp.

−70°C

storage temp.

-

storage temp.

-

storage temp.

−70°C

shipped in

dry ice

shipped in

wet ice

shipped in

dry ice

shipped in

-

specific activity

≥150,000 C9H50 units/mg (using C9 deficient serum)

specific activity

-

specific activity

-

specific activity

-


Lagerklasse

10 - Combustible liquids

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen